Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0002046433-26-000002

Options or other derivatives

  • Chief Medical Officer acquired 155,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McKee Charlotte Chief Medical Officer 2026-01-02 Grant or award · Non-Qualified Stock Option (right to buy) +155,700 155,700 D
Loading xslF345X05/edgardoc.xml…